drugset / Trial / NCT00513994

MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects

NCT00513994

Phase 1 Completed 6 enrolled MediQuest Therapeutics
CrossoverOpen-labelTreatment

Summary

The purpose of the study is to measure how much nitroglycerin or its metabolites may be found in the bloodstream when MQX-503 or an FDA approved Nitroglycerin ointment 2% USP is applied to the skin of healthy subjects.

Timeline

Start
2007-08
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitroglycerin Unknown 1 % Topical
Comparator Nitroglycerin Unknown 2 % Topical

Indications

No indication recorded.